| [1] |
张银维. 鲍曼不动杆菌血流感染临床特征和死亡危险因素研究[D]. 浙江大学. 2016.
|
| [2] |
陈佰义，何礼贤，胡必杰, 等. 中国鲍曼不动杆菌感染诊治与防控专家共识[J]. 中国医药科学,2012,2(8):13-18.
|
| [3] |
Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen[J]. Clin Microbiol Rev,2008,21(3):538-582.
|
| [4] |
Vijayakumar S, Mathur P, Kapil A, et al. Molecular characterization & epidemiology of carbapenem-resistant Acinetobacter baumannii collected across India[J]. Indian J Med Res,2019,149(2):240-246.
|
| [5] |
王金良. 密切注视鲍曼不动杆菌的耐药发展趋势[J]. 中华检验医学杂志,2005,28(4):355-356.
|
| [6] |
Correa A, Del Campo R, Escandón-Vargas K, et al. Distinct genetic diversity of carbapenem-resistant Acinetobacter baumannii from Colombian hospitals[J]. Microb Drug Resist,2017,24(1):48-54.
|
| [7] |
杨均均，黄文祥，史芳静, 等. 耐碳青霉烯鲍曼不动杆菌流行特征及耐药基因分析[J]. 中国抗生素杂志,2012,37(5):343-347.
|
| [8] |
Wong D, Nielsen TB, Bonomo RA, et al. Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges[J]. Clin Microbiol Rev,2017,30(1):409-447.
|
| [9] |
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twenty-fourth informational supplement[S]. CLSI document, approved standard M100-S24. Wayne (PA): The Institute; 2014.
|
| [10] |
Bartual SG, Seifert H, Hippler C, et al. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii[J]. J Clin Microbiol,2005,43(9):4382-4390.
|
| [11] |
凌保东. 鲍曼不动杆菌抗生素多重耐药性:耐药机制与感染治疗对策[J]. 中国抗生素杂志,2010,35(4):241-254.
|
| [12] |
Aly MM, Abu Alsoud NM, Elrobh MS, et al. High prevalence of the PER-1 gene among carbapenem-resistant Acinetobacter baumanniiin Riyadh, Saudi Arabia[J]. Eur J Clin Microbiol,2016,35(11):1759-1766.
|
| [13] |
Biglari S, Hanafiah A, Mohd Puzi S, et al. Antimicrobial resistance mechanisms and genetic diversity of multidrug-resistant Acinetobacter baumannii isolated from a teaching hospital in Malaysia[J]. Microb Drug Resist,2017,23(5):545-555.
|
| [14] |
Lee CR, Lee JH, Park KS, et al. Quantitative proteomic view associated with resistance to clinically important antibiotics in Gram-positive bacteria: a systematic review[J]. Front Microbiol,2015,6:828.
|
| [15] |
Liu Y, Liu X. Detection of AmpC β-lactamases in Acinetobacter baumannii in the Xuzhou region and analysis of drug resistance[J]. Exp Ther Med,2015,10(3):933-936.
|
| [16] |
Corvec S, Poirel L, Naas T, et al. Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii[J]. Antmicrob Agents Ch,2007,51(4):1530-1533.
|
| [17] |
Nigro SJ, Hall RM. Structure and context of Acinetobacter transposons carrying the oxa23 carbapenemase gene[J]. J Antimicrob Chemoth,2016,71(5):1135-1147.
|
| [18] |
Fournier PE, Vallenet D, Barbe V, et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii[J]. PLoS Genet,2006,2(1):62-72.
|
| [19] |
姜旻，孟现民，赵赟. 浅析近十年我国鲍曼不动杆菌检出率和耐药性变化[J]. 世界临床药物,2016,37(4):254-257.
|
| [20] |
Smani Y, Fàbrega A, Roca I, et al. Role of OmpA in the multidrug resistance phenotype of Acinetobacter baumannii[J]. Antmicrob Agents Ch,2014,58(3):1806-1808.
|
| [21] |
李志涛，张扣兴. 鲍曼不动杆菌的致病力毒力因素[J]. 中国抗生素杂志,2014,39(8):566-570.
|
| [22] |
McConnell M J, Actis L, Pachón J. Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models[J]. Fems Microbiol Rev,2013,37(2):130-155.
|
| [23] |
Vila-Farrés X, Ferrer-Navarro M, Callarisa AE, et al. Loss of LPS is involved in the virulence and resistance to colistin of colistin-resistant Acinetobacter nosocomialis mutants selected in vitro[J]. J Antimicrob Chemoth,2015,70(11):2981-2986.
|
| [24] |
Harding CM, Hennon SW, Feldman MF. Uncovering the mechanisms of Acinetobacter baumannii virulence[J]. Nat Rev Microbiol,2018,16(2):91.
|
| [25] |
Ali HM, Salem MZM, El-Shikh MS, et al. Investigation of the virulence factors and molecular characterization of the clonal relations of multidrug-resistant Acinetobacter baumannii isolates[J]. J Aoac Int,2017,100(1):152-158.
|
| [26] |
Lee CR, Lee JH, Park M, et al. Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options[J]. Front Cell Infect Microbiol,2017,7:55.
|
| [27] |
马晓春，代军，徐磊, 等. 鲍曼不动杆菌生物膜形成机制研究进展[J]. 中国感染与化疗杂志,2018,18(1):124-128.
|
| [28] |
Gaddy JA, Arivett BA, McConnell MJ, et al. Role of acinetobactin-mediated iron acquisition functions in the interaction of Acinetobacter baumannii strain ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars, and mice[J]. Infect Immun,2012,80(3):1015-1024.
|
| [29] |
Penwell WF, Arivett BA, Actis LA. The Acinetobacter baumannii entA gene located outside the Acinetobactin cluster is critical for siderophore production, iron acquisition and virulence[J]. PLoS One,2012,7(5):e36493.
|
| [30] |
Parsek MR, Fuqua C. Biofilms 2003: Emerging themes and challenges in studies of surface-associated microbial life[J]. J Bacteriol, 2004,186(14):4427-4440.
|